Guardian Pharmacy Services Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 1/31 in the Food & Drug Retailing industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 34.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Guardian Pharmacy Services Inc's Score
Industry at a Glance
Industry Ranking
1 / 31
Overall Ranking
57 / 4582
Industry
Food & Drug Retailing
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
34.000
Target Price
+18.80%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Guardian Pharmacy Services Inc Highlights
StrengthsRisks
Guardian Pharmacy Services, Inc. is a long-term care pharmacy services company. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 35.15% year-on-year.
Overvalued
The company’s latest PE is 46.64, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 18.78M shares, increasing 22.79% quarter-over-quarter.
Guardian Pharmacy Services, Inc. is a long-term care pharmacy services company. Through its locally based business model, it partners with long-term care facilities (LTCF0073) to deliver medications, and a comprehensive suite of technology-enabled services designed to enhance care and improve adherence to drug regimens, helping to reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle in order to manage medication risk. Its Guardian Compass platform offers insights to enhance efficiency for its pharmacies, including proprietary real-time operational dashboards and metrics. Its suite of GuardianShield products offers customer and clinical services that benefit both the residents it serves and their caregivers.
Ticker SymbolGRDN
CompanyGuardian Pharmacy Services Inc
CEOBurke (Fred P)
Websitehttps://guardianpharmacy.com/
FAQs
What is the current price of Guardian Pharmacy Services Inc (GRDN)?
The current price of Guardian Pharmacy Services Inc (GRDN) is 31.600.
What is the symbol of Guardian Pharmacy Services Inc?
The ticker symbol of Guardian Pharmacy Services Inc is GRDN.
What is the 52-week high of Guardian Pharmacy Services Inc?
The 52-week high of Guardian Pharmacy Services Inc is 37.430.
What is the 52-week low of Guardian Pharmacy Services Inc?
The 52-week low of Guardian Pharmacy Services Inc is 17.780.
What is the market capitalization of Guardian Pharmacy Services Inc?
The market capitalization of Guardian Pharmacy Services Inc is 2.00B.
What is the net income of Guardian Pharmacy Services Inc?
The net income of Guardian Pharmacy Services Inc is -110.05M.
Is Guardian Pharmacy Services Inc (GRDN) currently rated as Buy, Hold, or Sell?
According to analysts, Guardian Pharmacy Services Inc (GRDN) has an overall rating of --, with a price target of 34.000.
What is the Earnings Per Share (EPS TTM) of Guardian Pharmacy Services Inc (GRDN)?
The Earnings Per Share (EPS TTM) of Guardian Pharmacy Services Inc (GRDN) is 0.676.